• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • WORLD EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • WORLD EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Energy Market
Energy News
Energy Stocks
  • Energy Market
  • Energy News
  • Energy Stocks

Bannerman Resources Announces Completion of Etango Membrane Study

Written by Nicole Rashotte
|
Apr. 12, 2018 07:39AM PST

Bannerman Resources Limited announced that their Etango Membrane Study has been completed successfully.

Bannerman Resources Limited (ASX:BMN) announced that their Etango Membrane Study has been completed successfully, delivering substantial reagent/operating cost reductions along with forecast capital savings, the final quantum of which is to be confirmed in the Etango Definitive Feasibility Study Update.

Highlights are as follows:

Nano-filtration delivers substantial potential cost savings

  • Over 80% of acid recovered, reducing largest reagent cost
  • Corresponding decrease in acid-neutralisation chemical volumes
  • Potential capital savings through reduction in downstream equipment size

Membrane Study demonstrates nano-filtration benefits to Etango

  • Confirmed recovery of acid for re-use
  • Uranium solution upgraded almost ten-fold
  • Confirmed residual deleterious elements can be efficiently removed before uranium precipitation

Confirms Ion Exchange (IX) with nano-filtration (NF) favourable over Solvent Extraction (SX)

  • Enables IX/NF process to replace SX in DFS Update
  • Both economic and operational advantages in the IX/NF process route
  • Membrane Study provides valuable process input in DFS Update

Brandon Munro, CEO, commented:

The amenability of the Etango Project to recent advances in established nano-filtration technology is an exciting outcome that further confirms the robust economics and low technical risk of the Etango project.  Our technical team undertook the Membrane Study diligently and comprehensively, utilising the unique advantages Bannerman’s Heap Leach Demonstration Plant offers, in particular the access to industrial-scale uranium bearing solution generated from the Etango orebody.  I am delighted that this success further enhances Etango, both economically and operationally, as a world-class, highly-advanced and strategically important uranium project.

Click here to read the full Bannerman Resources Limited (ASX:BMN) press release.

asx:bmn
The Conversation (0)

Go Deeper

AI Powered
Basin Energy Logo

Basin Energy

Forum Energy Metals

Forum Energy Metals

Latest News

Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update

Generation Announces $350,000 Non-Brokered Flow Through Private Placement

BPH Energy Limited PEP11 Update: Advent Energy to Appeal Federal Court Judgement

PEP11 Update - Advent to appeal Federal Court Judgement

Generation Uranium Starts Summer 2026 Field Program at the Yath Project, Kivalliq Region, Nunavut. Project,

More News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES